VYNE
NASDAQ · Pharmaceuticals
Vyne Therapeutics Inc
$0.64
+0.00 (+0.71%)
Open$0.64
Previous Close$0.64
Day High$0.64
Day Low$0.64
52W High$1.96
52W Low$0.28
Volume—
Avg Volume282.9K
Market Cap22.33M
P/E Ratio—
EPS$-0.62
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+2,939.6% upside
Current
$0.64
$0.64
Target
$19.49
$19.49
$14.75
$19.49 avg
$26.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 463.1K | 437.3K | 2.72M |
| Net Income | -21,559,786 | -18,322,764 | 604.8K |
| Profit Margin | -4,646.1% | -4,413.8% | 22.3% |
| EBITDA | -21,744,326 | -19,506,241 | 831.2K |
| Free Cash Flow | — | — | 485.0K |
| Rev Growth | +5.9% | +5.9% | -5.6% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |